Advanced

A biology-driven approach identifies the hypoxia gene signature as a predictor of the outcome of neuroblastoma patients.

Paolo, Fardin; Annalisa, Barla; Sofia, Mosci; Rosasco, Lorenzo; Alessandro, Verri; Rogier, Versteeg; Huib N, Caron; Jan J, Molenaar; Øra, Ingrid LU and Alessandra,, Eva, et al. (2010) In Mol Cancer 12(9). p.185-185
Please use this url to cite or link to this publication:
author
, et al. (More)
(Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Mol Cancer
volume
12
issue
9
pages
185 - 185
external identifiers
  • scopus:77954419844
language
English
LU publication?
yes
id
f5329324-4589-45ec-a3b1-75bf75334255 (old id 1714347)
date added to LUP
2010-11-10 10:41:56
date last changed
2017-09-03 05:02:56
@article{f5329324-4589-45ec-a3b1-75bf75334255,
  author       = {Paolo, Fardin and Annalisa, Barla and Sofia, Mosci and Rosasco, Lorenzo and Alessandro, Verri and Rogier, Versteeg and Huib N, Caron and Jan J, Molenaar and Øra, Ingrid and Alessandra,, Eva and Maura, Puppo and Luigi, Varesio},
  language     = {eng},
  number       = {9},
  pages        = {185--185},
  series       = {Mol Cancer},
  title        = {A biology-driven approach identifies the hypoxia gene signature as a predictor of the outcome of neuroblastoma patients.},
  volume       = {12},
  year         = {2010},
}